Abstract

COSTABEL, Juan P. et al. Position statement for improvement in reperfusion of ST-elevation myocardial infarction in Latin America. Arch. Cardiol. Méx. [online]. 2024, vol.94, n.2, pp.208-218.  Epub May 14, 2024. ISSN 1665-1731.  https://doi.org/10.24875/acm.23000045.

The treatment of ST-segment elevation myocardial infarction has barriers depending on the geographic region. Primary coronary angioplasty is the treatment of choice, if it is performed on time and by experienced operators. However, when it is not available, the administration of fibrinolysis and referral for rescue angioplasty, in case of negative reperfusion, is the best strategy. In the same way, coronary angioplasty, as part of a pharmacoinvasive strategy, is the best alternative when there is positive reperfusion. The development of infarct treatment networks increases the number of patients reperfused within the recommended times and improves outcomes. In Latin America, national myocardial infarction treatment programs should focus on improving outcomes, and long-term success depends on working toward defined goals and enhancing functionality, therefore programs should develop capacity to measure their performance. The following document discusses all of these alternatives and suggests opportunities for improvement.

Keywords : Myocardial infarction; Reperfusion; Fibrinolysis; PCI.